ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.000001 per share (ACTU)

CUSIP: 005083100

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Common Stock, par value $0.000001 per share
Shares outstanding
23,561,857
Total 13F shares
382,167
Share change
+382,167
Total reported value
$2,847,155
Price per share
$7.45
Number of holders
10
Value change
+$2,847,155
Number of buys
10

Quarterly Holders Quick Answers

What is CUSIP 005083100?
CUSIP 005083100 identifies ACTU - ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.000001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ACTU - ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.000001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Bios Clinical Opportunity Fund, LP
3/4/5
10%+ Owner —
class O/S missing
231,377
 — — 12 Aug 2024
3/4/5
Bios 2024 Co-Invest, LP
3/4/5
Director, Member of 10% Group —
class O/S missing
125,000
 — — 14 Aug 2024
3/4/5

Institutional Holders of ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.000001 per share (ACTU) as of Q3 2024

As of 30 Sep 2024, ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.000001 per share (ACTU) was held by 10 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 382,167 shares. The largest 10 holders included AWM Investment Company, Inc., Long Corridor Asset Management Ltd, Royal Bank of Canada, GEODE CAPITAL MANAGEMENT, LLC, NORTHWESTERN UNIVERSITY, KG&L Capital Management,LLC, CITIGROUP INC, WELLS FARGO & COMPANY/MN, Tower Research Capital LLC (TRC), and BANK OF AMERICA CORP /DE/. This page lists 10 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2024 vs Q4 2025 Across Filers

Q4 2025 holders
44
Q3 2024 holders
10
Holder diff
-34
Investor Q4 2025 Shares Q3 2024 Shares Share Diff Share Chg % Q4 2025 Value $ Q3 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .